BlackRock Fund Advisors - INOTEK PHARMACEUTICALS CORP ownership

INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102. A total of 53 filers reported holding INOTEK PHARMACEUTICALS CORP in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of INOTEK PHARMACEUTICALS CORP
ValueSharesWeighting
Q4 2016$3,368,000
-57.5%
552,073
-33.9%
0.00%
-50.0%
Q3 2016$7,921,000
+35.1%
835,508
+6.0%
0.00%
+100.0%
Q2 2016$5,865,000
+120.4%
788,315
+119.2%
0.00%0.0%
Q1 2016$2,661,000
-28.1%
359,612
+10.1%
0.00%0.0%
Q4 2015$3,701,000
+2257.3%
326,618
+1850.2%
0.00%
Q3 2015$157,00016,7480.00%
Other shareholders

There were no reported owners of INOTEK PHARMACEUTICALS CORP in Q3 2015.

NameSharesValueWeighting ↓
View complete list of INOTEK PHARMACEUTICALS CORP shareholders